Poniedziałek - Piątek - 8:00 - 19:00, Sobota - 9:00 - 13:00
DZIAŁALNOŚĆ NAUKOWO-BADAWCZA

dr n. med. Anna Janicka

dr n. med. Anna Janicka

  • Medycyna wspomaganego rozrodu w Polsce – raport za rok 2012 Sekcji Płodności i Niepłodności Polskiego Towarzystwa Ginekologicznego (SPiN PTG) – LINK
  • Polymorphisms in the oxidative stress-related genes and cancer risk – LINK
  • Ustawa o leczeniu niepłodności – LINK
  • Wykorzystanie USG w ocenie stymulacji jajeczkowania – LINK
  • Assisted reproductive medicine in Poland, 2011-SPiN PTG report – LINK
  • Polymorphisms in the oxidative stress-related genes and cancer risk – LINK
  • Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? – LINK
  • Hereditary breast and ovarian cancer – LINK
  • DNA testing for variants conferring low or moderate increase in the risk of cancer – LINK
  • Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology – LINK
  • Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology – LINK
  • Breast cancer susceptibility genes – LINK
  • BARD1 and breast cancer in Poland – LINK
  • CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors – LINK
  • Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma – LINK
  • CDKN2A common variant and multi-organ cancer risk–a population-based study – LINK
  • Low-risk Genes and Multi-organ Cancer Risk in the Polish Population – LINK
  • Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer – LINK
  • The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs – LINK
  • CHEK2 is a multiorgan cancer susceptibility gene – LINK